Your Location:
Home >
Browse articles >
Downregulation of FTO aggravates osteoarthritis with obesity by erasing m6A methylation of PDP2
Downregulation of FTO aggravates osteoarthritis with obesity by erasing m6A methylation of PDP2
- “A new study reveals FTO gene downregulation drives obesity-related osteoarthritis progression through the FTO/YTHDF2/PDP2 axis, offering promising therapeutic targets for this degenerative joint disease.”
- Military Medical Research (2026)
DOI: 10.1016/j.mmr.2026.100054
Accepted:09 July 2026
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 8 ) Tabs( 0 )
References
Publication Info
Metrics
21
Views
2
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Role of signaling pathways in age-related orthopedic diseases: focus on the fibroblast growth factor family
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
Related Author
Heng-Zhen Li
Jing-lve Zhang
Dong-Liang Yuan
Wen-Qing Xie
Christoph H. Ladel
Ali Mobasheri
Yu-Sheng Li
Wang-Lin Duan
Related Institution
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University
World Health Organization Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Université de Liège
Department of Joint Surgery, the First Affiliated Hospital of Sun Yat-sen University
Department of Rheumatology and Clinical Immunology, Universitair Medisch Centrum Utrecht
Department of Regenerative Medicine, State Research Institute Centre for Innovative Medicine

